The Hill lab at UCLA studies a peculiar type of parasite known as Trypanosoma brucei, which causes a serious illness called sleeping sickness in humans and livestock. Their research focuses on understanding the structure and function of the parasite's flagellum, a tail-like structure crucial for its movement and interaction with its environment. The lab utilizes advanced microscopy techniques to explore how these parasites assemble their flagella and how this knowledge can lead to new ways of treating diseases caused by similar parasites.

Dr. Alexander Hoffmann's lab at UCLA focuses on understanding how macrophages, which are crucial immune cells, respond to different stimuli and pathogens. The lab studies the mechanisms behind macrophage immune training, which is when past exposures reshape their future responses. By analyzing how these cells undergo epigenomic changes and how different transcription factors like IRFs shape their behavior, the lab aims to uncover insights that could inform treatments for infectious and inflammatory diseases.

Dr. April Pyle's lab at UCLA focuses on understanding how skeletal muscle cells develop from human pluripotent stem cells (hPSCs). They study the differences between these stem cells and adult muscle stem cells to improve their ability to generate healthier muscle cells for research and potential therapies. By investigating and enhancing how these cells behave in a lab setting, they aim to create better models for muscle diseases and advance regenerative medicine.

Dr. Timothy E. O'Sullivan's lab focuses on understanding how human natural killer (NK) cells function, especially in the context of viral infections like cytomegalovirus, which is particularly dangerous for newborns and immunocompromised individuals. By investigating the transcriptional regulators like MEF2C, the lab aims to develop strategies to enhance NK cell activity, potentially leading to new treatments for patients who are at high risk for these infections. This research combines molecular biology and immunology to improve health outcomes.

Dr. Maureen A. Su's lab focuses on understanding how the immune system contributes to autoimmune diseases, particularly those affecting hormone-producing tissues. They explore the role of genetic and epigenetic factors in these conditions, investigating how differences in male and female immune responses can impact disease outcomes. The lab combines expertise from various fields to identify new targets for immunotherapy that can improve patient care in autoimmune endocrinopathies and enhance viral infection responses.

Dr. Yvonne Yu-Hsuan Chen's lab focuses on developing innovative immunotherapy approaches for treating glioblastoma multiforme (GBM), a highly aggressive brain tumor. The lab's key strategy is to engineer CAR-T cells that target specific tumor markers while also modifying the surrounding tumor environment to enhance immune response. Their work includes rigorous safety evaluations and aims to generate essential preclinical data to support clinical trials for GBM treatments.

Dr. Douglas L. Black's lab at UCLA focuses on understanding how RNA binding proteins regulate gene expression, particularly through alternative splicing. Their research not only explores the intricate interactions between proteins and RNA but also aims to uncover the mechanisms that lead to misregulation in diseases such as neurodegeneration and cancer. By mapping binding sites of key proteins involved in splicing, they hope to enhance the ability to predict pathogenic mutations affecting gene regulation.

Dr. Jing Wen's lab at UCLA focuses on developing innovative solutions to combat HIV, especially in infants. They are exploring a new method to deliver broadly neutralizing antibodies (bNAbs) more effectively across the blood-brain barrier to target infections and reservoirs in the central nervous system (CNS). This research is crucial for improving treatments for infants infected with HIV and reducing neurological complications related to the virus.